About Voronoi
Voronoi is a publicly listed company based in Incheon (South Korea) founded in 2015. Development and manufacturing of drugs for autoimmune diseases are undertaken. The company has 147 employees. Its focus areas include Diversified Pharmaceuticals.
Company details
Voronoi was founded in 2015 and is headquartered in Incheon, South Korea. Operations in the biotechnology sector center on the development of therapeutics targeting autoimmune diseases. Research and manufacturing processes are conducted to advance drug candidates for clinical applications. The companys activities are supported by facilities in South Korea, with a focus on innovative solutions within the pharmaceutical industry. The domain voronoi.io serves as the primary online resource.
- Headquarters Incheon, South Korea
- Employees 147
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website voronoi.io
- Legal Name Voronoi, Inc.
- Annual Revenue$5.2 M (USD)as on Dec 31, 2025
- Net Profit-$29.57 M (USD)-30.95as on Dec 31, 2025
- EBITDA-$36.42 M (USD)-53.02as on Dec 31, 2025
- Employee Count147
IPO & Listings of Voronoi
Voronoi is a publicly listed company on the KRX with ticker symbol 310210 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Jun 2022
- Listed onKRX: 310210
- Listed entityVoronoi, Inc.
- Exchange sectorHealth technology
- ISINKR7310210000
- Share price118,200.00 KRW (+0.51% on the day) · 2026-10-14
- Market capitalisation2,189,307,678,223.00 KRW
- EPS (diluted, trailing year)-3,790.49 KRW
- Volume (last session)67,393
Financials of Voronoi
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 7.51B KRW | -42.71B KRW | -52.60B KRW |
| 2024 | -32.61B KRW | -34.37B KRW | |
| 2023 | -36.85B KRW | -28.63B KRW | |
| 2022 | 9.77B KRW | -19.90B KRW | -15.49B KRW |
| 2021 | 14.78B KRW | -15.10B KRW | -7.61B KRW |
Detailed financial statements for Voronoi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Voronoi
The website of Voronoi (voronoi.io) receives about 9.7K visits a month and ranks #1,484,394 among all websites worldwide, #1,952 in Biotechnology and Pharmaceuticals.
- Monthly visits9.7K
▼ 19.1% vs previous month
- Unique visitors4.3K
per month
- Global rank#1,484,394
among all websites
- Category rank#1,952
Health · Biotechnology and Pharmaceuticals
- Bounce rate30%
- Pages per visit4.0
- Average visit1 min 31 sec
- DevicesDesktop 51% · Mobile 49%
Websites whose visitors overlap most with Voronoi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
newsmp.com | newsmp.com | 100% | #330,463 | – | |
| biotimes.co.kr | 94% | #456,742 | View details | ||
| hitnews.co.kr | 94% | #146,502 | View details | ||
docdocdoc.co.kr | docdocdoc.co.kr | 94% | #141,726 | – | |
bosa.co.kr | bosa.co.kr | 94% | #127,846 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Voronoi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Voronoi
Complete news archive for Voronoi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Voronoi
Voronoi was founded in 2015.
Voronoi is headquartered in Incheon, South Korea.
Voronoi has 147 employees.
Annual revenue of Voronoi is $5.2M as on Dec 31, 2025.
Voronoi was founded in 2015 and is headquartered in Incheon, South Korea. Operations in the biotechnology sector center on the development of therapeutics targeting autoimmune diseases. Research and manufacturing processes are conducted to advance drug candidates for clinical applications. The companys activities are supported by facilities in South Korea, with a focus on innovative solutions within the pharmaceutical industry. The domain voronoi.io serves as the primary online resource.
Yes, Voronoi is publicly traded on KRX under the ticker symbol 310210.